Rea, Federico http://orcid.org/0000-0001-7988-5101
,
Calusi, Giulia
Franchi, Matteo
Vetrano, Davide Liborio
Roberto, Giuseppe
Bonassi, Stefano
Kirchmayer, Ursula
Chinellato, Alessandro
Bettiol, Alessandra
Sultana, Janet
Mugelli, Alessandro
Corrao, Giovanni
Funding for this research was provided by:
Agenzia Italiana del Farmaco, Ministero della Salute (AIFA-FARM9LBBBL)
Article History
First Online: 26 October 2018
Compliance with Ethical Standards
:
: This study was funded by a research grant from the Italian Medicines Agency (AIFA, project AIFA-FARM9LBBBL), Rome, Italy. Data analyses were performed at the Laboratory of Healthcare Research & Pharmacoepidemiology, University of Milano-Bicocca with grants from the Italian Ministry of Education, Universities and Research (MIUR) [’Fondo d’Ateneo per la Ricerca’ portion, year 2015].
: Alessandro Mugelli received research support from the Italian Medicines Agency (AIFA), the Italian Ministry of Education, Universities and Research (MIUR), Gilead and Menarini. In the last 2 years, he received personal fees as a speaker/consultant for the Menarini Group, IBSA, Molteni, Angelini and Pfizer Alliance. Giovanni Corrao received research support from the European Community, AIFA and MIUR. He participated in a variety of projects funded by pharmaceutical companies (i.e. Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as a member of an advisory board for Roche. Federico Rea, Giulia Calusi, Matteo Franchi, Davide Liborio Vetrano, Giuseppe Roberto, Stefano Bonassi, Ursula Kirchmayer, Alessandro Chinellato, Alessandra Bettiol and Janet Sultana have no conflicts of interest that are directly relevant to the contents of this study.
: This study was approved by the Ethics Committee of “Azienda Ospedaliera Universitaria di Careggi”, Florence, Italy, on 26 March, 2012; Protocol Number: 2012/0012643.